Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPAR

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. NTSK
10. OLLI

Go back to Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPAR
(NASDAQ: ENSC) Delayed: 0.45 +0.01 (2.27%)
Previous Close $0.44    52 Week High $ 
Open $0.44    52 Week Low $ 
Day High $0.45    P/E N/A 
Day Low $0.43    EPS $ 
Volume 301,448